Gujarat Terce Laboratories Ltd.
BSE: 524314
₹37.62
₹0.71
(1.92%)
As on 26-Aug-2026IST
Market cap
₹29 Cr
Revenue (TTM)
₹46 Cr
P/E Ratio
14
P/B Ratio
3.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
27.8 %
-
ROCE
34.8 %
-
Industry P/E
33.76
-
EV/EBITDA
6.9
-
Debt to Equity
0.1
-
Book Value
₹12.3
-
EPS
₹3.1
-
Face value
10
-
Shares outstanding
7,791,300
10 Years Aggregate
CFO
₹9.41 Cr
EBITDA
₹6.66 Cr
Net Profit
₹-0.89 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gujarat Terce Lab
| -13.5 | 7.8 | 6.9 | -15.3 | 22.2 | 23.3 | 15.5 |
|
BSE Healthcare
| 17.7 | 3.5 | 7.6 | 14.1 | 22.7 | 14.7 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Gujarat Terce Lab
| -48.5 | 197.0 | 56.1 | 0.1 | 106.9 | 9.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gujarat Terce Lab
|
37.6 | 29.3 | 45.6 | 2.1 | 6.2 | 26.4 | 14 | 3.1 |
| 7,153.0 | 17,888.6 | 2,432.1 | 169.6 | 8.7 | 20.8 | 105.5 | 19.8 | |
| 2,516.3 | 19,147.4 | 2,287.3 | 678.1 | 31.4 | 19.7 | 28.8 | 5.1 | |
| 2,103.1 | 12,881.8 | 1,479.1 | 198.6 | 18.6 | 30.3 | 64.7 | 16.0 | |
| 1,310.7 | 18,136.4 | 3,229.7 | 666.9 | 26.6 | 18.8 | 28.2 | 4.5 | |
| 4,802.5 | 21,951.1 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.9 | 5.0 | |
| 5,766.0 | 9,570.6 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.8 | 15.5 | |
| 3,191.2 | 7,347.9 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.7 | 8.9 | |
| 860.8 | 16,822.0 | 1,682.5 | 273.5 | 21.0 | 11.1 | 56.6 | 6.3 | |
| 982.9 | 9,061.5 | 5,004.4 | 635.3 | 14.5 | 19.8 | 14.8 | 2.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Gujarat Terce Lab
Gujarat Terce Laboratories Limited manufactures and markets medical and pharmaceutical preparations in India. The company offers branded and generic formulations covering various therapeutic, such as antibiotics, respiratory, nutraceuticals,... gastrointestinal, anti-fungal, and others. It provides its products in various forms, such as tablets, capsules, oral liquids, injections, and ointments. The company also exports its products. Gujarat Terce Laboratories Limited was founded in 1985 and is based in Ahmedabad, India. Read more
-
Incorporated
1985
-
Chairman
--
-
Managing Director
Aalap Prajapati
-
Headquarters
Gandhinagar, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Gujarat Terce Lab
What is the current share price of Gujarat Terce Laboratories Ltd Today?
The share price of Gujarat Terce Laboratories Ltd is ₹37.62 (BSE) as of 26-Aug-2026 IST. Gujarat Terce Laboratories Ltd has given a return of 22.21% in the last 3 years.
What is the current PB & PE ratio of Gujarat Terce Laboratories Ltd?
The P/E ratio of Gujarat Terce Laboratories Ltd is 14.02 times as on 26-Aug-2026, a 58 discount to its peers’ median range of 33.76 times.
The P/B ratio of Gujarat Terce Laboratories Ltd is 3.07 times as on 26-Aug-2026, a 38 discount to its peers’ median range of 4.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
10.94 |
2.47 |
2025 |
0.00 |
7.40 |
2024 |
161.33 |
5.53 |
2023 |
0.00 |
1.80 |
2022 |
22.24 |
2.27 |
What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?
The 52-week high and low of Gujarat Terce Laboratories Ltd are Rs 59.78 and Rs 29.00 as of 27-Aug-2026.
What is the market cap of Gujarat Terce Laboratories Ltd?
Gujarat Terce Laboratories Ltd has a market capitalisation of ₹ 29 Cr as on 26-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Gujarat Terce Laboratories Ltd?
Before investing in Gujarat Terce Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.